1. Home
  2. Documents

Medicines and Health Technologies Documents

Date Range
CD58/INF/14 - Progress Reports on Technical Matters: Strengthening National Regulatory Authorities for Medicines and Biologicals: Progress Report
Mandates and Strategies
Post-authorization Surveillance of Medical Products during a Pandemic Emergency, 21 July 2020
Post-authorization Surveillance of Medical Products during a Pandemic Emergency, 21 July 2020
Technical and scientific products
Considerations for Regulatory Oversight of Clinical Trials in COVID-19
Considerations for Regulatory Oversight of Clinical Trials in the COVID-19 Pandemic
Technical and scientific products
Blood services cover publication
Supply of Blood for Transfusion in Latin America and Caribbean Countries 2016-2017
Technical and scientific products
Reprocessing of respirators during shortages
Technical and regulatory aspects of the extended use, reuse, and reprocessing of respirators during shortages
Technical and scientific products
Regulation of Medical Devices in the context of COVID-19
Regulation of Medical Devices in the context of COVID-19
Technical and scientific products
Ethics guidance for the use of scarce resource - critical health COVID-19
Ethics guidance for the use of scarce resources in the delivery of critical health care during the COVID-19 pandemic
Technical and scientific products
Guidance and strategies to streamline ethics review and oversight of COVID-19
Guidance and strategies to streamline ethics review and oversight of COVID-19 related research
Technical and scientific products
Essential Medicines List for Management of Patients - COVID19
Essential Medicines List for Management of Patients admitted to Intensive Care Units with Suspected or Confirmed COVID-19 Diagnosis
Technical reports
Ibuprofen and COVID-19 (Washington, DC. 18 March, 2020)
Other publications
Cover.Reorganization and Progressive Expansion of Health
Reorganization and Progressive Expansion of Health Services for the Response to the COVID-19 Pandemic
Technical and scientific products
Presentation - Infection Prevention and Control and Novel Coronavirus (COVID-19): standard precautions and use of personal protective equipment
Technical and scientific products
Agenda. IX Pan American Network for Drug Regulatory Harmonization Conference. San Salvador, El Salvador. “Regulatory Harmonization Contributions to the Achievement of Health for All” Commemorating 20 years of PANDRH and 40 years of Alma-Ata.
Presentation - Conclusions and adoption of the recommendations of the IX CPARF (only in Spanish)
Presentations
(C. Luwis, M. Freitas). PANDRH Project update: Assessing CPP requirement for medicines registration – presentation of the preliminary outcomes.
Presentations
Presentation - Innovative Pharmaceutical Development Approaches require strong Regulatory Systems – An Industry Perspective
Presentations
Brochure - World Antibiotic Awareness Week 2018: Pharmaceutical Industry (Printing Version)
Brochures
cover
Access and rational use of strategic and high-cost medicines and other health technologies
Mandates and Strategies
VIII CPANDRH Agenda. Oct. 2016
Thematic Session 03: PANDRH Secretariat: Adoption and implementation of prioritization model for PANDRH operation (Murilo Freitas Dias, PAHO/WHO)
document
CD55.R12 - Access and Rational Use of Strategic and High-cost Medicines and Other Health Technologies
Mandates and Strategies